Please wait while the formulary information is being retrieved.
Drug overview for REESE'S PINWORM (pyrantel pamoate):
Generic name: PYRANTEL PAMOATE (pye-RAN-tel)
Drug class: Anthelmintics
Therapeutic class: Anti-Infective Agents
Pyrantel pamoate is a pyrimidine-derivative anthelmintic agent.
No enhanced Uses information available for this drug.
Generic name: PYRANTEL PAMOATE (pye-RAN-tel)
Drug class: Anthelmintics
Therapeutic class: Anti-Infective Agents
Pyrantel pamoate is a pyrimidine-derivative anthelmintic agent.
No enhanced Uses information available for this drug.
DRUG IMAGES
REESE'S PINWORM 144 MG/ML SUSP
The following indications for REESE'S PINWORM (pyrantel pamoate) have been approved by the FDA:
Indications:
Ascariasis
Enterobiasis
Mixed intestinal helminthiasis
Professional Synonyms:
Infestation by Ascaris lumbricoides
Multiple helminth infection
Oxyuriasis
Threadworm infection
Indications:
Ascariasis
Enterobiasis
Mixed intestinal helminthiasis
Professional Synonyms:
Infestation by Ascaris lumbricoides
Multiple helminth infection
Oxyuriasis
Threadworm infection
The following dosing information is available for REESE'S PINWORM (pyrantel pamoate):
Dosage of pyrantel pamoate is expressed in terms of pyrantel.
Pyrantel pamoate is administered orally. Pyrantel pamoate may be taken without regard to meals, and may be taken or mixed with milk or fruit juice. The oral suspension should be shaken well prior to using.
Special diet, fasting, or purgation prior to administration of pyrantel pamoate is not necessary. Patients should be advised of hygienic precautions needed to minimize reinfection. Patients undertaking self-medication of enterobiasis should be provided information supplied by the manufacturer that describes dosage, hygienic precautions needed to minimize reinfection, symptoms of pinworm infections, the worm's life cycle, and how to locate and identify the worm. The presence of pinworms should be confirmed visually before initiating self-medication.
Special diet, fasting, or purgation prior to administration of pyrantel pamoate is not necessary. Patients should be advised of hygienic precautions needed to minimize reinfection. Patients undertaking self-medication of enterobiasis should be provided information supplied by the manufacturer that describes dosage, hygienic precautions needed to minimize reinfection, symptoms of pinworm infections, the worm's life cycle, and how to locate and identify the worm. The presence of pinworms should be confirmed visually before initiating self-medication.
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| REESE'S PINWORM 144 MG/ML SUSP | Maintenance | Adults take 11 mg/kg by oral route once, not to exceed 1 gram |
No generic dosing information available.
The following drug interaction information is available for REESE'S PINWORM (pyrantel pamoate):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for REESE'S PINWORM (pyrantel pamoate):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| No disease contraindications |
The following adverse reaction information is available for REESE'S PINWORM (pyrantel pamoate):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 1 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. | None. |
| Rare/Very Rare |
|---|
|
Skin rash |
There are 9 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Abdominal pain with cramps Anorexia Diarrhea Dizziness Drowsy Headache disorder Insomnia Nausea Vomiting |
| Rare/Very Rare |
|---|
| None. |
The following precautions are available for REESE'S PINWORM (pyrantel pamoate):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Reproduction studies in animals using pyrantel pamoate have not revealed evidence of harm to the fetus. There also was no evidence of impaired fertility in rats. There are no adequate and controlled studies to date using pyrantel pamoate in pregnant women, and the drug should be used during pregnancy only when clearly needed. Pregnant women considering self-medication with the drug should do so only under the direction of a clinician.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for REESE'S PINWORM (pyrantel pamoate):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for REESE'S PINWORM (pyrantel pamoate)'s list of indications:
| Ascariasis | |
| B77 | Ascariasis |
| B77.0 | Ascariasis with intestinal complications |
| B77.8 | Ascariasis with other complications |
| B77.81 | Ascariasis pneumonia |
| B77.89 | Ascariasis with other complications |
| B77.9 | Ascariasis, unspecified |
| Enterobiasis | |
| B80 | Enterobiasis |
| Mixed intestinal helminthiasis | |
| B81.4 | Mixed intestinal helminthiases |
Formulary Reference Tool